Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01154998
Recruitment Status : Unknown
Verified June 2010 by St George's Healthcare NHS Trust.
Recruitment status was:  Not yet recruiting
First Posted : July 1, 2010
Last Update Posted : July 1, 2010
Sponsor:
Information provided by:
St George's Healthcare NHS Trust

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.

Condition or disease
Idiopathic Pulmonary Fibrosis Interstitial Pneumonia

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 360 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Case-Control Study of Fibrotic Interstitial Lung Disease and it's Association With Cardiac Disease or Cardiac Intervention.
Study Start Date : July 2010
Estimated Primary Completion Date : January 2011
Estimated Study Completion Date : April 2011

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Cases
Controls


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cases - patients with IPF or UIP. Controls - hospital clinic attenders.
Criteria

Inclusion Criteria:

  • idiopathic fibrotic lung disease

Exclusion Criteria:

  • non idiopathic fibrotic lung disease
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154998


Contacts
Layout table for location contacts
Contact: Felix Chua, MBBS 0208 725 1261 felix.chua@stgeorges.nhs.uk

Locations
Layout table for location information
United Kingdom
St George's Hospital
London, United Kingdom, SW17 0QT
Sponsors and Collaborators
St George's Healthcare NHS Trust
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Dr Felix Chua, St George's Healthcare NHS Trust
ClinicalTrials.gov Identifier: NCT01154998    
Other Study ID Numbers: 10/H1102/46
First Posted: July 1, 2010    Key Record Dates
Last Update Posted: July 1, 2010
Last Verified: June 2010
Keywords provided by St George's Healthcare NHS Trust:
non-specific interstitial pneumonia
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia
Lung Diseases
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Lung Diseases, Interstitial
 Heart Diseases
Respiratory Tract Infections
Infections
Respiratory Tract Diseases
Cardiovascular Diseases